Delaware Supreme Court upholds Fresenius/Akorn decision
Delaware’s highest state court has confirmed that healthcare company Fresenius was entitled to pull out of its multibillion-dollar acquisition of Akorn after finding that the generic drugmaker had misrepresented the state of its data.
To read more
Subscribe to Global Data Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Data Review experts.